Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02125357
Title Sequencing Abiraterone and Enzalutamide in mCRPC
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications
Therapies
Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
BC Cancer Agency - Abbotsford Abbotsford British Columbia V2S 0C2 Canada Details
BC Cancer Agency - Southern Interior Kelowna British Columbia V1Y 5L3 Canada Details
BC Cancer Agency - Centre for the North Prince George British Columbia V2N 7E9 Canada Details
BC Cancer Agency - Fraser Valley Surrey British Columbia V3V 1Z2 Canada Details
Vancouver Prostate Centre Vancouver British Columbia V5Z 1M9 Canada Details
BC Cancer Agency - Vancouver Centre Vancouver British Columbia V5Z 4E6 Canada Details
BC Cancer Agency - Vancouver Island Victoria British Columbia V8R 6V5 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field